BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12687017)

  • 1. Partial oncogenic transformation of chicken embryo fibroblasts by Jun dimerization protein 2, a negative regulator of TRE- and CRE-dependent transcription.
    Blazek E; Wasmer S; Kruse U; Aronheim A; Aoki M; Vogt PK
    Oncogene; 2003 Apr; 22(14):2151-9. PubMed ID: 12687017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
    Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coupling of folding and DNA-binding in the bZIP domains of Jun-Fos heterodimeric transcription factor.
    Seldeen KL; McDonald CB; Deegan BJ; Farooq A
    Arch Biochem Biophys; 2008 May; 473(1):48-60. PubMed ID: 18316037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of basic region leucine zipper transcription factors cyclic AMP response element binding protein (CREB), CREB2, activating transcription factor 2 and CAAT/enhancer binding protein alpha in cyclic AMP response element-mediated transcription.
    Thiel G; Al Sarraj J; Vinson C; Stefano L; Bach K
    J Neurochem; 2005 Jan; 92(2):321-36. PubMed ID: 15663480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial oncoproteins: modified versions of the yeast bZip protein GCN4 induce cellular transformation.
    Nishizawa M; Fu SL; Kataoka K; Vogt PK
    Oncogene; 2003 Sep; 22(39):7931-41. PubMed ID: 12970741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterodimerization with c-Fos is not required for cell transformation of chicken embryo fibroblasts by Jun.
    Hughes M; Sehgal A; Hadman M; Bos T
    Cell Growth Differ; 1992 Dec; 3(12):889-97. PubMed ID: 1472469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation by Jun: requirement for leucine zipper, basic region and transactivation domain and enhancement by Fos.
    Morgan IM; Ransone LJ; Bos TJ; Verma IM; Vogt PK
    Oncogene; 1992 Jun; 7(6):1119-25. PubMed ID: 1594243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis.
    van Dam H; Castellazzi M
    Oncogene; 2001 Apr; 20(19):2453-64. PubMed ID: 11402340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of jun transformation by a mutated fos gene: design of an anti-oncogene.
    Okuno H; Suzuki T; Yoshida T; Hashimoto Y; Curran T; Iba H
    Oncogene; 1991 Sep; 6(9):1491-7. PubMed ID: 1923517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of trans-activating capacity of CRE-BPa by phorbol ester tumor promoter TPA.
    Zu YL; Maekawa T; Nomura N; Nakata T; Ishii S
    Oncogene; 1993 Oct; 8(10):2749-58. PubMed ID: 8378084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factor ATF3 partially transforms chick embryo fibroblasts by promoting growth factor-independent proliferation.
    Perez S; Vial E; van Dam H; Castellazzi M
    Oncogene; 2001 Mar; 20(9):1135-41. PubMed ID: 11314051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of gene transcription by a constitutively active mutant of activating transcription factor 2 (ATF2).
    Steinmüller L; Thiel G
    Biol Chem; 2003 Apr; 384(4):667-72. PubMed ID: 12751796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Directed mutation of the basic domain of v-Jun alters DNA binding specificity and abolishes its oncogenic activity in chicken embryo fibroblasts.
    Basso J; Briggs J; Findlay C; Bos T
    Oncogene; 2000 Oct; 19(42):4876-85. PubMed ID: 11039905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Fos protein containing the Jun leucine zipper forms a homodimer which binds to the AP1 binding site.
    Neuberg M; Adamkiewicz J; Hunter JB; Müller R
    Nature; 1989 Sep; 341(6239):243-5. PubMed ID: 2506451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leucine zippers of fos, jun and GCN4 dictate dimerization specificity and thereby control DNA binding.
    Kouzarides T; Ziff E
    Nature; 1989 Aug; 340(6234):568-71. PubMed ID: 2505081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The c-Jun dimerization protein 2 inhibits cell transformation and acts as a tumor suppressor gene.
    Heinrich R; Livne E; Ben-Izhak O; Aronheim A
    J Biol Chem; 2004 Feb; 279(7):5708-15. PubMed ID: 14627710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of GTP cyclohydrolase I gene transcription by basic region leucine zipper transcription factors.
    Al Sarraj J; Vinson C; Han J; Thiel G
    J Cell Biochem; 2005 Dec; 96(5):1003-20. PubMed ID: 16149046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic transformation by Jun: role of transactivation and homodimerization.
    Hartl M; Vogt PK
    Cell Growth Differ; 1992 Dec; 3(12):899-908. PubMed ID: 1472470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secalonic acid D alters the nature of and inhibits the binding of the transcription factors to the phorbol 12-O-tetradecanoate-13 acetate-response element in the developing murine secondary palate.
    Balasubramanian G; Hanumegowda U; Reddy CS
    Toxicol Appl Pharmacol; 2000 Dec; 169(2):142-50. PubMed ID: 11097866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of positively charged tripeptide to N-terminus of the Fos basic region leucine zipper domain: implications on DNA bending, affinity, and specificity.
    Mahmoudi T; Sarkar B
    Biopolymers; 1999 Sep; 50(3):273-86. PubMed ID: 10397789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.